Search results
Chasing down a cellular 'short circuit'
Science Daily· 7 days agoThe recent study, published in the journal Science Signaling, explores the biochemical mechanism that can interrupt the cellular communication chain -- a disruptive interaction that Pradipta ...
6 things to know before serving cheese, according to experts
Today· 6 days agoNew research indicates that cheese is leading the dairy category in the U.S.; while milk consumption...
TD Asset Management Inc Purchases New Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
ETF DAILY NEWS· 16 hours agoTD Asset Management Inc acquired a new stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with ...
Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment
Morningstar· 5 days agoRelay Therapeutics will collaborate with Pfizer to study atirmociclib in combination with RLY-2608 and fulvestrant in patients with certain types of metastatic breast cancer. Under the terms ...
Leukemia drug passes final trial phase with flying colors
Medical Xpress· 6 days agoAsciminib, is known by the brand name Scemblix, produced by Swiss-based, Novartis Pharma AG. It...
Is aortic valve stenosis hereditary? Research and more
Medical News Today· 4 days agoAortic valve stenosis (AVS) can result from heart abnormalities that may be hereditary, but it...
VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of...
Morningstar· 7 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Ventyx Biosciences, Inc. (NASDAQ: VTYX) on behalf of long-term stockholders ...
Symptoms of CML Getting Worse
Healthline· 3 days agoLearn how symptoms of chronic myeloid leukemia (CML) may change as it progresses through chronic, accelerated, and blast phases.
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 7 days agoLive from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety PR Newswire SUZHOU, China ...
Newswise Expert | Afshin Dowlati, Case Western Reserve University
Newswise· 4 days agoFrom a clinical standpoint, I have led the thoracic program at Case Western Reserve University since 2000. My research is focused on the translational aspects of target validation and drug development ...